Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer’s disease: a focused review on recent advances
Joyce R. Chong(National University of Singapore), Mitchell K.P. Lai(National University of Singapore), Kaj Blennow(Sahlgrenska University Hospital), Tomotaka Tanaka(Shimane University), Nicholas J. Ashton(Alzheimer's Association), Michael Schöll(National Hospital for Neurology and Neurosurgery), Henrik Zetterberg(Queen Mary University of London), Thomas K. Karikari(University of Pittsburgh), Christopher Chen(National University of Singapore)
Cited by 111
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k